Orforglipron 12mg — TFC Peptides

Orforglipron 12mg (100 Tablets)

SKU: TFC-ORF12
Brand:
Brand TFC Peptides200 followers
$195.00

In Stock

A non-peptide GLP-1 receptor agonist designed for oral absorption and tested in big clinical programs for obesity and type 2 diabetes; it hits an incretin target without being an incretin-like peptide.

  • In the kit: 100 × 12mg
  • Cost per mg: $0.163
  • Third-party report: Not on file yet
  • Dispatches from: China
Bulk pricingCombine any TFC Peptides products: each kit from this vendor counts toward your discount tier.
  1. 1–4 kits$195.00full price
  2. 5+ kits$185.255% off
  3. 10+ kits$175.5010% off
  4. 20+ kits$171.6012% off
  5. 50+ kits$165.7515% off
  6. 100+ kits$156.0020% off
ß

Minimum order $100.00 across all brands, before the escrow fee.

◆
Escrow-protected purchaseYour payment is held by us — the brand is only paid after you confirm delivery.
↺
Refund if not deliveredOpen a claim from your order page; upheld claims are refunded to your Escrow Wallet.
✓
Sold by TFC PeptidesVetted vendor · ships from China
⚗
Lab testingNo public report for this listing yet. We can request the batch COA before you order. What to test →

For research use only. Not for human consumption. Not medical advice.

Log in to watch this price

TFC Peptides offers 100 vials of 12mg (1200 mg altogether), dispatched from Tianjin, China. You pay $195.00 for the kit, which comes to $0.163/mg. Funds sit in escrow until delivery is confirmed, then they are released to TFC Peptides.

This listing: TFC Peptides Orforglipron

Other strengths
6mg $115.00

Lab testing

There is no public lab report for this listing yet. We can ask the brand for the batch COA before you order. Many buyers also split an independent HPLC test with others who bought the same batch.

Request the batch COA · How group testing works

Bought through escrow: the brand is only paid after you confirm delivery. If the parcel never arrives, or an independent test shows the wrong compound or a significant under-fill, open a claim before releasing payment.

About Orforglipron

Most GLP-1 drugs people know, such as semaglutide and liraglutide, are modified copies of a peptide hormone. Orforglipron breaks that pattern. It is a made-in-the-flask small molecule discovered by Chugai Pharmaceutical, with Eli Lilly taking over clinical development under license. Its architecture has nothing in common with GLP-1, and the design aim was uptake through the gut without the absorption enhancers that oral peptide formulations need. The marketplace lists it as a research material.

Research focus

Like peptide incretins, orforglipron switches on the GLP-1 receptor, but it grips a different region and in a different way than the natural hormone does. It is characterized as a biased agonist that leans toward G-protein and cAMP output and away from beta-arrestin recruitment. Receptor activation as a class is investigated for glucose-dependent insulin secretion, slower stomach emptying and dampened appetite signals. Whether bias actually changes results against peptide agonists is unanswered. Comparisons with peptide agonists therefore focus on binding behavior and signaling profile, not shared structure.

Where Orforglipron stands

Eli Lilly has conducted extensive Phase 3 work in obesity and type 2 diabetes, with several studies already reporting. Because regulatory review is in motion, the current position should be checked directly with the relevant agency before anyone cites it. Material on a research marketplace is not a licensed medicine and should not be treated as equal to any approved or pending product.

Checking a certificate

Different chemistry, different tests. For a small molecule, the strongest evidence is LC-MS identity against the expected molecular mass, backed by NMR or a reference-standard comparison, plus HPLC purity with its chromatogram. Content per unit against the label, residual solvent results and a note on appearance add confidence. Amino-acid analysis, a staple of peptide reports, is irrelevant here.

This listing has no independent certificate on file so far. Browse the lab reports directory to compare brands that do test, or read Testing 101 before ordering.

Kit details

Active compound
Orforglipron
Per vial
12mg
Vials in kit
100
Total in kit
1200 mg
Cost per mg
$0.163
Dispatches from
Tianjin, China
Third-party report
Not on file yet

Keeping the vials

Keep the powder sealed and refrigerated or frozen, protected from moisture and light. A reconstituted solution belongs in the fridge, used within the window your study protocol allows.

For concentration maths: a 12mg vial made up to 1 mL is 12 mg/mL; made up to 2 mL it is 6 mg/mL, and to 3 mL about 4 mg/mL. Other volumes can be worked out with the Research Lab calculator in your dashboard.

Buyer FAQ

What follows from orforglipron not being a peptide?

Peptides tend to be digested in the gut, one reason most approved GLP-1 drugs are injectables. A small molecule can be absorbed more easily and is produced by routine chemical synthesis instead of peptide manufacturing. For researchers it is also a structurally distinct probe of the same receptor.

Is it a version of semaglutide?

No. They share only a target. Semaglutide is an engineered form of the GLP-1 peptide, while orforglipron is an unrelated chemical structure that grips the receptor differently and is made by a different process. Results from one should not be carried across to the other.

What exactly is in this kit?

100 vials at 12mg each, 1200 mg in total. No lab report is attached yet, so the label figures have not been independently confirmed.

When is TFC Peptides paid?

It stays in escrow until you confirm delivery; only then is it released to TFC Peptides. If the order is missing or not as described, open a claim before releasing and the held amount can be refunded to your Escrow Wallet.

For in-vitro and laboratory research only. Not for human or veterinary use and not a replacement for any prescribed medicine. Nothing here is medical advice.

Reviews

There are no reviews yet.

0.00

Average of 0 reviews

0 reviews
0 reviews
0 reviews
0 reviews
0 reviews
Be the first to review “Orforglipron 12mg (100 Tablets)”

Your email address will not be published. Required fields are marked *